Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cardlytics, Inc.

Cardlytics, Inc. (CDLX) Stock Overview

Explore Cardlytics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CDLX●NASDAQ
Communication ServicesAdvertising Agencies
$4.26
$0.06(1.43%)
U.S. Market opens in 12h 0m

Cardlytics, Inc. (CDLX)

Meyka AI Score

Z

Key Financials

Market Cap24.7M
P/E Ratio-0.23
EPS (TTM)$-3.81
ROE12.85%
Fundamental Analysis

AI Price Forecasts

1 Month$3.37
3 Months$7.28
1 Year Target$5.63

CDLX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cardlytics, Inc. (NASDAQ: CDLX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Cardlytics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CDLX on the NASDAQ shows an RSI of 54.73, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.63 for the NASDAQ listing.

Key metrics behind Cardlytics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.23 and a market capitalization of 24.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CDLX on the NASDAQ.

Price Performance (NASDAQ: CDLX)

1-Day Change
1.43%
5-Day Change
22.06%
1-Month Change
2.16%
3-Month Change
-35.94%
6-Month Change
-54.29%
Year-to-Date (YTD) Change
-62.96%
1-Year Change
-67.48%
3-Year Change
-96.88%
5-Year Change
-99.47%
All-Time (Max) Change
-96.81%

Contact Information

https://www.cardlytics.com
888 798 5802
675 Ponce de Leon Avenue NE, Atlanta, GA, 30308

Company Facts

2,750 Employees
IPO DateFeb 9, 2018
CountryUS
Actively Trading

Frequently Asked Questions